thrombosis造句151) ObjectiveTo investigate the effect of Myricetin Dispersible Tablets on experimental cerebral ischemia-reperfusion injury in rats and thrombosis formation.
152) Ischemic cerebral apoplexy includes transient ischemic attack, cerebral thrombosis, cerebral embolism.
153) A study on the clinical characteristic of cerebral vein and sinus thrombosis in 11cases.
154) Examples of infectious-inflammatory states predisposing to SSS thrombosis are sinusitis, mastoiditis, trauma, and sarcoidosis.
155) Objective : To observe the effect of makin in restraining thrombosis in vivo of experimental mice.
156) Objective: To observe the effects of deep venous thrombosis patients treating by filter implantation and operation.
157) Results:Angiography demonstrated hepatic arterial thrombosis in 3 cases, anastomotic stenosis of hepatic artery in 1, hepatopetal arterial collaterals in 2, and portal vein dilatation in 3 patients.
158) D - dimer; lower extremity deep venous thrombosis; thrombolytic therapy; urokinase.
159) Tongxinluo in the application of the blood and stop bleeding-min, Agrimony of drugs, such as bleeding, blood coagulation due to the increase in thrombosis, can lead to a stroke.
160) Results Of all the patients, hemostasis successfully achieved , without venous sinus thrombosis, re - bleeding and intracranial infection.
161) Objective To explore the risk factors of portal system thrombosis after splenectomy in patient with portal hypertension.
162) We present a patient with spontaneous femoral artery thrombosis that recurred after successful embolectomy and anticoagulant therapy.
163) Objective To study the preventing methods of hepatic artery thrombosis after liver transplantation.
164) Formation of thrombosis is the major factor for the different clinical manifestations of erythromelalgia , which should be early diagnosed and treated with anti-platelet drugs.
165) Objective:To evaluate the characteristics of portal vein tumor thrombosis on helical CT and CT portography (CTP).
166) Objective To assess the efficacy and safety of interventional techniques for the management of symptomatic portal vein (PV) and superior mesenteric vein (SMV) thrombosis.
167) Objective To evaluate the safety of intraluminal ultrasonic ablation angioplasty for human venous thrombosis.
168) Objective To study the efficacy of nicergoline through a few different deliveries in treatment of thrombosis in rat.
169) Cerbral thrombosis is a kind of blood-supply disord in brain, which is originated by many agents. Parts of brain tissues may emerge ischemia and anoxemia, then cause cellular necrosis or emolliating.
170) Objective : To investigate the clinical characteristics of cerebral venous sinus thrombosis ( CVST ).
171) Objective : To investigate the relation between embolic event and left atrial thrombosis.
172) In addition we expect the coumadin, this drug is much more efficacious in preventing thrombosis in patients with atrial fibrillation and it has significantly less side effects.
173) Aim To observe the effect of phenolic alkaloids of Menispermum dauricum (PAMD) on thrombosis and platelet aggregation, and to explore its mechanism of action.
174) These complications include shock, the nerve and vascular injury, the acute kidney failure, fat embolism, infection, deep venous thrombosis, decubitus ulcer and so on.
175) Objective To study the effects of the arachidonic acid (AA) and eicosapentaenic acid (EPA) on the occurrence of cerebral thrombosis and the secondary brain injury.
176) Objective: To investigate the clinical significance of measuring indexes related to thrombosis in treating diabetes hypercoagulable state and preventing its complications in patients with diabetes.
177) It is generally accepted that thinning of the blood reduces the chances of thrombosis.
178) Result: All the patients were cured. 12 patients complicated by venous thrombosis healed with good appearance.
179) To evaluate the value of color Doppler ultrasound to muscular veniplex thrombosis of calf.
180) Vitamin K can stop bleeding, but large doses can cause a potentially fatal thrombosis.